{
    "nctId": "NCT06572098",
    "briefTitle": "The Effect of Complex Decongest\u0131ve Therapy on Ox\u0131dat\u0131ve Stress and Ant\u0131ox\u0131dants",
    "officialTitle": "The Effect of Complex Decongest\u0131ve Therapy on Ox\u0131dat\u0131ve Stress and Ant\u0131ox\u0131dants In Pat\u0131ents W\u0131th Lymphedema After Breast Cancer Treatment",
    "overallStatus": "ENROLLING_BY_INVITATION",
    "conditions": "What Are the Effects of Lymphedema Treatment",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NON_RANDOMIZED",
    "primaryPurpose": "HEALTH_SERVICES_RESEARCH",
    "enrollmentCount": 52,
    "primaryOutcomeMeasure": "PON1",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Development of lymphedema after breast cancer treatment\n* Clinical stage of lymphedema Stage-2 or Stage-3 diagnosis\n\nExclusion Criteria:\n\n* Receiving treatment for lymphedema in the last three months\n* Those diagnosed with severe heart failure and/or arrhythmia\n* Persistent infection in the affected extremities\n* Ongoing chemotherapy treatment\n* Diagnosed with liver disease",
    "sex": "FEMALE",
    "minimumAge": "25 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}